Toll-like receptor 7 regulates cardiovascular diseases

Role of Toll‐like receptors in the pathogenesis of COVID‐19

(2021) Shaghayegh Khanmohammadi et al.   JOURNAL OF MEDICAL VIROLOGY

Toll-Like Receptor 7 Stimulation Promotes the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice

(2020) Alexander O. Krogmann et al.   International Heart Journal

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs

(2020) Abhigyan Choudhury et al.   JOURNAL OF MEDICAL VIROLOGY

Role of TLR4 in physical exercise and cardiovascular diseases

(2020) Larissa G. de Vicente et al.   CYTOKINE

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

(2020) Gregory A. Roth et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction

(2019) Dominique P V de Kleijn et al.   CARDIOVASCULAR RESEARCH

Targeting the Immune System in Atherosclerosis

(2019) Tian X. Zhao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The role of platelets in mediating a response to human influenza infection

(2019) Milka Koupenova et al.   Nature Communications

Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque

(2018) Roberto Carnevale et al.   Scientific Reports

Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies

(2018) Cristina Cappelletti et al.   Nucleus

Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy

(2018) Lifang Zhao et al.   Journal of Immunology Research

Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies

(2018) Cristina Cappelletti et al.   Nucleus

Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block

(2018) Robert M. Clancy et al.   JOURNAL OF IMMUNOLOGY

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8

(2017) Peter Larson et al.   ACS Medicinal Chemistry Letters

TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells and protects mice from lethal influenza infection

(2017) Laure Perrin-Cocon et al.   Scientific Reports

LowTLR7gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events

(2016) Glykeria Karadimou et al.   CARDIOVASCULAR RESEARCH

Myocarditis

(2016) Gabriel Fung et al.   CIRCULATION RESEARCH

NETosis markers: Quest for specific, objective, and quantitative markers

(2016) Sakiko Masuda et al.   CLINICA CHIMICA ACTA

Immune system and cardiovascular disease

(2016) Irene Fernández-Ruiz   Nature Reviews Cardiology

Toll-Like Receptor 7-Targeted Therapy in Respiratory Disease

(2016) Katie M. Lebold et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

TLR signalling and association of TLR polymorphism with cardiovascular diseases

(2016) Swati Sharma et al.   VASCULAR PHARMACOLOGY

Endosomal Toll-like receptors in clinically overt and silent autoimmunity

(2015) Robert M. Clancy et al.   IMMUNOLOGICAL REVIEWS

Cardiac RNA Induces Inflammatory Responses in Cardiomyocytes and Immune CellsviaToll-like Receptor 7 Signaling

(2015) Yan Feng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inflammation and plaque vulnerability

(2015) G. K. Hansson et al.   JOURNAL OF INTERNAL MEDICINE

Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma

(2014) Fatma E. Mohamed et al.   LIVER INTERNATIONAL

Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis

(2014) Mohammad Zare-Bidaki et al.   VIRAL IMMUNOLOGY

Low-Density Lipoprotein-Cholesterol-Induced Endothelial Dysfunction and Oxidative Stress: The Role of Statins

(2013) Nerea Hermida et al.   ANTIOXIDANTS & REDOX SIGNALING

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

(2013) Peter Libby et al.   IMMUNITY

Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration

(2012) Jacco C. Karper et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation

(2012) Maria Salagianni et al.   CIRCULATION

Role of Toll-like receptors in cardiovascular diseases

(2011) Jesus G. Vallejo   CLINICAL SCIENCE

Toll-like receptors as potential therapeutic targets in cardiac dysfunction

(2011) Ulrich Hofmann et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo

(2011) Norliana Khairuddin et al.   IMMUNOLOGY AND CELL BIOLOGY

Innate immune signaling in cardiac ischemia

(2011) Fatih Arslan et al.   Nature Reviews Cardiology

Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis

(2010) Philippe P. Pagni et al.   AUTOIMMUNITY

Ro60-Associated Single-Stranded RNA Links Inflammation with Fetal Cardiac Fibrosis via Ligation of TLRs: A Novel Pathway to Autoimmune-Associated Heart Block

(2010) Robert M. Clancy et al.   JOURNAL OF IMMUNOLOGY

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Toll-like receptors and innate immunity

(2009) Himanshu Kumar et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Innate Immunity and Toll-like Receptor Antagonists: A Potential Role in the Treatment of Cardiovascular Diseases

(2009) Elaine Lin et al.   Cardiovascular Therapeutics

The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents

(2009) Amani Makkouk et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Recognition of viral single-stranded RNA by Toll-like receptors☆

(2008) S DIEBOLD   ADVANCED DRUG DELIVERY REVIEWS

Statins inhibit Rho kinase activity in patients with atherosclerosis

(2008) Anju Nohria et al.   ATHEROSCLEROSIS

Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?

(2008) Athanasios Katsargyris et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes

(2008) Valentina Loria et al.   MEDIATORS OF INFLAMMATION

TLR signaling by tumor and immune cells: a double-edged sword

(2008) B Huang et al.   ONCOGENE